CiteULike is a free online bibliography manager. Register and you can start organising your references online.
Tags

Mineralocorticoid receptor blockade in chronic kidney disease.

by: Andrew S. Bomback, Philip J. Klemmer
Blood purification, Vol. 33, No. 1-3. (2012), pp. 119-124, doi:10.1159/000334161  Key: citeulike:11896774

Formatted Citation


Show HTML

Likes (beta)

This copy of the article hasn't been liked by anyone yet.

View FullText article


Abstract

Mineralocorticoid receptor blockers (MRBs) have proven highly successful in the treatment of congestive heart failure and resistant hypertension. In contrast, their use in chronic kidney disease (CKD) has lagged due to the concern of hyperkalemia and, possibly, because of the incorrect assumption that traditional therapy with angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers consistently reduce aldosterone activity in all patients. Low-dose MRB therapy may offer additional antihypertensive and unique anti-inflammatory benefits in select CKD populations. Copyright © 2012 S. Karger AG, Basel.


guhjy's tags for this article

Citations (CiTO)

No CiTO relationships defined

X There are no reviews yet

X Find related articles with these CiteULike tags

X Posting History


X Export records

Privacy Statement | Terms & Conditions
CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.